How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine Saad ShakirSamantha LaneMiranda Davies Editorial Open access 21 November 2020 Pages: 1 - 5
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry Alexandra SimbrichJasmine Thibautfor the REGIMS Investigators Special Article Open access 23 October 2020 Pages: 7 - 15
Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations Tanja PetersNigel SoanesOn behalf of the EFPIA International Pharmacovigilance Group Review Article Open access 08 December 2020 Pages: 17 - 28
Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis Tianshu RenShu WangQingchun Zhao Systematic Review 12 November 2020 Pages: 29 - 40
Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa Ushma MehtaMariette SmithMarc Blockman Original Research Article Open access 25 August 2020 Pages: 41 - 51
Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study Clément MathieuPierre JolyAntoine Pariente Original Research Article 30 October 2020 Pages: 53 - 62
Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe Reynold D. C. FranciscaEmna BabaSabine M. J. M. Straus Original Research Article Open access 30 September 2020 Pages: 63 - 72
Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors Christina E. HoeveEsther de VriesSabine M. J. M. Straus Original Research Article Open access 23 December 2020 Pages: 73 - 82
ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance Samuel BayerCheryl ClarkRobert Ball Original Research Article Open access 02 October 2020 Pages: 83 - 94
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective Elena BeyzarovYan ChenPatrick Caubel Original Research Article Open access 22 December 2020 Pages: 95 - 105
Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System Henry TrumboKarolina KaluzaLawrence T. Goodnough Original Research Article Open access 25 November 2020 Pages: 107 - 119
Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-Reporting Björn KoneswarakanthaYves BarmazDonato Rolo Research Letter 04 October 2020 Pages: 121 - 123